Francois Nader Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Francois Nader.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Francois Nader. Francois Nader is Chief Medical & Commercial Off in NPS PHARMACEUTICALS INC ($NPSP) and Chief Operating Officer in NPS PHARMACEUTICALS INC ($NPSP) and President, CEO and Director in NPS PHARMACEUTICALS INC ($NPSP) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in ACCELERON PHARMA INC ($XLRN) and Director in TREVENA INC ($TRVN) and Director in Baxalta Inc ($BXLT) and Director in Moderna, Inc. ($MRNA) and Director in Prevail Therapeutics Inc. ($PRVL).
Latest Insider Trading Transactions of Francois Nader
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, ALXN, BXLT, MRNA, NPSP, PRVL, TRVN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
| Apr 30 2021 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 10.26 | 32,000 | 328,320 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 2.81 | 133,447 | 374,986 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Sell | U | 0.00 | 23,747 | 0 | 0 | 23.7 K to 0 (-100.00 %) |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Nader Francois | Director | Grant | A | 0.00 | 941 | 0 | 11,286 | 10.3 K to 11.3 K (+9.10 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Nader Francois | Director | Grant | A | 0.00 | 3,468 | 0 | 10,345 | 6.9 K to 10.3 K (+50.43 %) |
| Apr 30 2020 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Grant | A | 0.00 | 1,377 | 0 | 5,127 | 3.8 K to 5.1 K (+36.72 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 18.87 | 17,889 | 337,565 | 17,889 | |
| Dec 11 2019 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 18.87 | 39,720 | 749,516 | 39,720 | |
| Jun 25 2019 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | C | 0.00 | 23,747 | 0 | 0 | |
| Jun 25 2019 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Buy | C | 0.00 | 23,747 | 0 | 23,747 | 0 to 23.7 K |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Grant | A | 0.00 | 1,250 | 0 | 3,750 | 2.5 K to 3.8 K (+50.00 %) |
| May 11 2018 | ALXN | ALEXION PHARMACEUT ... | Nader Francois | Director | Grant | A | 0.00 | 2,174 | 0 | 4,151 | 2 K to 4.2 K (+109.96 %) |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Grant | A | 0.00 | 1,250 | 0 | 2,500 | 1.3 K to 2.5 K (+100.00 %) |
| Nov 30 2017 | ALXN | ALEXION PHARMACEUT ... | Nader Francois | Director | Grant | A | 0.00 | 1,977 | 0 | 1,977 | 0 to 2 K |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Grant | A | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Jun 07 2016 | BXLT | Baxalta Inc | Nader Francois | Director | Option Exercise | D | 30.60 | 5,960 | 182,376 | 0 | |
| Jun 07 2016 | BXLT | Baxalta Inc | Nader Francois | Director | Sell | D | 0.00 | 7,657 | 0 | 0 | 7.7 K to 0 (-100.00 %) |
| May 12 2016 | BXLT | Baxalta Inc | Nader Francois | Director | Grant | A | 0.00 | 4,500 | 0 | 7,657 | 3.2 K to 7.7 K (+142.54 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Jul 29 2015 | BXLT | Baxalta Inc | Nader Francois | Director | Option Exercise | A | 30.60 | 5,960 | 182,376 | 5,960 | |
| Jul 29 2015 | BXLT | Baxalta Inc | Nader Francois | Director | Grant | A | 0.00 | 3,140 | 0 | 3,140 | 6.3 K to 3.1 K (-50.00 %) |
| May 21 2015 | TRVN | TREVENA INC | Nader Francois | Director | Option Exercise | A | 6.80 | 8,870 | 60,316 | 8,870 | |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 34.14 | 10,000 | 341,400 | 10,000 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 0.00 | 115,432 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 0.00 | 27,926 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 0.00 | 24,302 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 0.00 | 19,598 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 0.00 | 80,912 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 5.71 | 109,602 | 625,827 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 5.71 | 82,826 | 472,936 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 3.25 | 67,636 | 219,817 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 3.34 | 154,284 | 515,309 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 8.25 | 133,125 | 1,098,281 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 8.21 | 104,438 | 857,436 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 8.23 | 196,018 | 1,613,228 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Option Exercise | D | 38.27 | 106,643 | 4,081,228 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | President, CEO and ... | Sell | U | 46.00 | 276,955 | 12,739,930 | 0 | 277 K to 0 (-100.00 %) |
| Sep 12 2007 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Operating Off ... | Option Exercise | A | 4.29 | 94,714 | 406,323 | 94,714 | |
| Jul 18 2007 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 4.42 | 8,875 | 39,228 | 8,875 | |
| Jul 18 2007 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 4.13 | 64,500 | 266,385 | 64,500 | |
| Apr 18 2007 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 4.31 | 8,875 | 38,251 | 8,875 | |
| Jan 18 2007 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 4.37 | 8,875 | 38,784 | 8,875 | |
| Oct 19 2006 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 0.00 | 86,134 | 0 | 86,134 | |
| Oct 18 2006 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 4.50 | 8,875 | 39,938 | 8,875 | |
| Oct 18 2006 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 4.07 | 8,875 | 36,121 | 8,875 | |
| Jun 07 2006 | NPSP | NPS PHARMACEUTICAL ... | Nader Francois | Chief Medical & Com ... | Option Exercise | A | 5.73 | 100,000 | 573,000 | 100,000 |
Page: 1